• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分析前要求。

Pre-analytical requirements.

作者信息

Livesey John H, Ellis M Jane, Evans Margaret J

机构信息

Endolab, Christchurch Hospital, Christchurch 8140, New Zealand.

出版信息

Clin Biochem Rev. 2008 Aug;29 Suppl 1(Suppl 1):S11-5.

PMID:18852848
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2556574/
Abstract

Correct test selection: a test must have the potential to alter patient management and have the specificity and sensitivity appropriate to the pretest probability of disease. Correct dynamic test procedure: dynamic tests may assist diagnosis and protocols must be readily available. Correct patient preparation: fasting, or other patient preparation, may reduce variability. Clear communication, to both patients and staff, of any such requirements is essential. Correct sample collection: the tube type (for blood) or container (for urine) must be appropriate for the analyte; there must be sufficient volume, avoidance of venous stasis, contaminants and haemolysis; and adequate labelling. Correct sample handling: the time and temperature before and after separation, and the centrifugation and separation procedures, must be suitable for the analyte. Accept/reject criteria must be defined. Methods require thorough evaluation of patient-related pre-analytical factors, and quantification of the effects of time, temperature, haemolysis, anticoagulant type and minimum allowable volume on sample suitability.

摘要

正确的检测选择

检测必须有可能改变患者的治疗管理,并且具有与疾病的检测前概率相适应的特异性和敏感性。正确的动态检测程序:动态检测可能有助于诊断,且必须随时可获取相关方案。正确的患者准备:禁食或其他患者准备措施可能会减少变异性。向患者和工作人员清晰传达任何此类要求至关重要。正确的样本采集:(用于血液的)试管类型或(用于尿液的)容器必须适合分析物;必须有足够的量,避免静脉淤滞、污染和溶血;并且要有适当的标签。正确的样本处理:分离前后的时间和温度,以及离心和分离程序,必须适合分析物。必须定义接受/拒绝标准。方法需要对与患者相关的分析前因素进行全面评估,并量化时间、温度、溶血、抗凝剂类型和最小允许体积对样本适用性的影响。

相似文献

1
Pre-analytical requirements.分析前要求。
Clin Biochem Rev. 2008 Aug;29 Suppl 1(Suppl 1):S11-5.
2
Quantitative determination of BAF312, a S1P-R modulator, in human urine by LC-MS/MS: prevention and recovery of lost analyte due to container surface adsorption.采用 LC-MS/MS 法定量测定人尿液中的 S1P-R 调节剂 BAF312:防止和恢复因容器表面吸附而损失的分析物。
J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Feb 15;878(5-6):583-9. doi: 10.1016/j.jchromb.2009.12.031. Epub 2010 Jan 4.
3
Pre-analytical factors affecting the results of laboratory blood analyses in farm animal veterinary diagnostics.影响兽医诊断中农场动物实验室血液分析结果的分析前因素。
Animal. 2012 Jul;6(7):1115-23. doi: 10.1017/S1751731111002679.
4
Feasibility and quality development of biomaterials in the pretest studies of the German National Cohort.德国国家队列预试验研究中生物材料的可行性与质量发展
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014 Nov;57(11):1255-63. doi: 10.1007/s00103-014-2048-7.
5
Blood venous sample collection: Recommendations overview and a checklist to improve quality.静脉血样采集:建议概述及提高质量的检查表
Clin Biochem. 2017 Jul;50(10-11):568-573. doi: 10.1016/j.clinbiochem.2017.02.021. Epub 2017 Feb 27.
6
Blood biochemical markers of bone turnover: pre-analytical and technical aspects of sample collection and handling.骨转换的血液生化标志物:样本采集和处理的分析前和技术方面。
Clin Chem Lab Med. 2012 Feb 3;50(5):771-89. doi: 10.1515/cclm-2011-0614.
7
Sample Management: Recommendation for Best Practices and Harmonization from the Global Bioanalysis Consortium Harmonization Team.样本管理:全球生物分析联盟协调团队关于最佳实践与协调的建议
AAPS J. 2016 Mar;18(2):290-3. doi: 10.1208/s12248-016-9869-2. Epub 2016 Jan 28.
8
Translational Metabolomics of Head Injury: Exploring Dysfunctional Cerebral Metabolism with Ex Vivo NMR Spectroscopy-Based Metabolite Quantification头部损伤的转化代谢组学:基于体外核磁共振波谱的代谢物定量分析探索脑代谢功能障碍
9
Setting acceptance criteria for validation of analytical methods of drug eluting stents: Minimum requirements for analytical variability.确立药物洗脱支架分析方法验证的验收标准:分析变异性的最低要求。
Eur J Pharm Sci. 2011 Feb 14;42(3):230-7. doi: 10.1016/j.ejps.2010.11.013. Epub 2010 Nov 30.
10
Optimization of analytical and pre-analytical conditions for MALDI-TOF-MS human urine protein profiles.优化 MALDI-TOF-MS 人尿液蛋白质谱的分析和前分析条件。
J Pharm Biomed Anal. 2010 Mar 11;51(4):907-14. doi: 10.1016/j.jpba.2009.10.014. Epub 2009 Oct 30.

引用本文的文献

1
Bias in Laboratory Medicine: The Dark Side of the Moon.实验室医学中的偏倚:月亮的暗面。
Ann Lab Med. 2024 Jan 1;44(1):6-20. doi: 10.3343/alm.2024.44.1.6. Epub 2023 Sep 4.
2
Preservation of Proteins in Human Plasma through Metal-Organic Framework Encapsulation.通过金属有机框架封装保存人血浆中的蛋白质。
ACS Appl Mater Interfaces. 2023 Apr 19;15(15):18598-18607. doi: 10.1021/acsami.2c21192. Epub 2023 Apr 4.
3
Guidelines for pre-analytical conditions for assessing the methylation of circulating cell-free DNA.循环游离 DNA 甲基化评估的分析前条件指南。
Clin Epigenetics. 2021 Oct 18;13(1):193. doi: 10.1186/s13148-021-01182-7.
4
Variable blood processing procedures contribute to plasma proteomic variability.可变的血液处理程序导致血浆蛋白质组的变异性。
Clin Proteomics. 2021 Jan 19;18(1):5. doi: 10.1186/s12014-021-09311-3.
5
The Clinical Potential of Circulating miRNAs as Biomarkers: Present and Future Applications for Diagnosis and Prognosis of Age-Associated Bone Diseases.循环 microRNAs 作为生物标志物的临床潜力:用于诊断和预测与年龄相关的骨骼疾病的当前和未来应用。
Biomolecules. 2020 Apr 11;10(4):589. doi: 10.3390/biom10040589.
6
Perspectives on miRNAs as Epigenetic Markers in Osteoporosis and Bone Fracture Risk: A Step Forward in Personalized Diagnosis.关于微小RNA作为骨质疏松症和骨折风险的表观遗传标记物的观点:个性化诊断的新进展
Front Genet. 2019 Oct 30;10:1044. doi: 10.3389/fgene.2019.01044. eCollection 2019.
7
Proteomic Approaches for the Discovery of Biofluid Biomarkers of Neurodegenerative Dementias.用于发现神经退行性痴呆生物流体生物标志物的蛋白质组学方法
Proteomes. 2018 Aug 31;6(3):32. doi: 10.3390/proteomes6030032.
8
[Preanalytics and biobanking : Influence of preanalytical factors on tissue sample quality].[分析前阶段与生物样本库:分析前因素对组织样本质量的影响]
Pathologe. 2018 Jul;39(4):297-302. doi: 10.1007/s00292-018-0437-7.
9
Current laboratory requirements for adrenocorticotropic hormone and renin/aldosterone sample handling are unnecessarily restrictive.目前对于促肾上腺皮质激素以及肾素/醛固酮样本处理的实验室要求限制过多,并无必要。
Clin Med (Lond). 2017 Feb;17(1):18-21. doi: 10.7861/clinmedicine.17-1-18.
10
A guide for measurement of circulating metabolic hormones in rodents: Pitfalls during the pre-analytical phase.啮齿动物循环代谢激素测量指南:分析前阶段的陷阱。
Mol Metab. 2012 Aug 9;1(1-2):47-60. doi: 10.1016/j.molmet.2012.07.004. eCollection 2012.

本文引用的文献

1
Urinary free cortisol and cortisone excretion in healthy individuals: influence of water loading.
Steroids. 2006 Nov;71(11-12):1014-8. doi: 10.1016/j.steroids.2006.08.004. Epub 2006 Sep 28.
2
Errors in clinical laboratories or errors in laboratory medicine?临床实验室的错误还是检验医学的错误?
Clin Chem Lab Med. 2006;44(6):750-9. doi: 10.1515/CCLM.2006.123.
3
Influence of hemolysis on routine clinical chemistry testing.溶血对常规临床化学检测的影响。
Clin Chem Lab Med. 2006;44(3):311-6. doi: 10.1515/CCLM.2006.054.
4
The impact of peer management on test-ordering behavior.同伴管理对检验医嘱行为的影响。
Ann Intern Med. 2004 Aug 3;141(3):196-204. doi: 10.7326/0003-4819-141-3-200408030-00008.
5
The haemolysis of human red blood-cells by freezing and thawing.人类红细胞通过冻融作用发生的溶血现象。
Biochim Biophys Acta. 1953 Mar;10(3):414-26. doi: 10.1016/0006-3002(53)90273-x.
6
Appropriateness in programs for continuous quality improvement in clinical laboratories.
Clin Chim Acta. 2003 Jul 15;333(2):131-9. doi: 10.1016/s0009-8981(03)00177-3.
7
Hormone stability in human whole blood.激素在人全血中的稳定性。
Clin Biochem. 2003 Mar;36(2):109-12. doi: 10.1016/s0009-9120(02)00440-x.
8
Effect of anticoagulants and storage temperatures on stability of plasma and serum hormones.抗凝剂和储存温度对血浆及血清激素稳定性的影响
Clin Biochem. 2001 Mar;34(2):107-12. doi: 10.1016/s0009-9120(01)00196-5.
9
Effects of repeated freeze-thaw cycles on concentrations of cholesterol, micronutrients, and hormones in human plasma and serum.反复冻融循环对人血浆和血清中胆固醇、微量营养素及激素浓度的影响。
Clin Chem. 2001 Jan;47(1):139-42.
10
Insulin measurements in haemolysed serum: influence of insulinase inhibitors.溶血血清中胰岛素的测定:胰岛素酶抑制剂的影响
Clin Chim Acta. 1998 Jun 8;274(1):111-7. doi: 10.1016/s0009-8981(98)00051-5.